Business Wire

Klarna and Visa Launch Pilot of New Debit Card with Increased Flexibility at Money 2020 Europe

Share

Klarna, the AI-powered payments and commerce network, unveiled the pilot launch of Klarna Card: a new debit product combined with access to built-in flexible payment options, powered by Visa Flexible Credential and issued by WebBank. Unlike traditional credit cards that can see consumers incur additional debt and interest charges, the Klarna Card will allow consumers to pay immediately or pay later when needed - online or in-store - at more than 150 million Visa-accepting merchants worldwide.

The Klarna Card is currently in a trial phase in the U.S., gathering feedback to refine the experience before a broader rollout in the U.S. and Europe expected later this year. This phased approach supports feature refinements, performance optimization, and ensures the product delivers a smarter, more flexible spending tool.

With over 5 million consumers already on the waitlist, the Klarna Card is the boldest step yet toward Klarna becoming an everyday spending solution in the U.S. The card comes with an FDIC-insured wallet, which allows consumers to store money and make real-time transfers, and deposits, and integrates directly with the Klarna Pay in 4 and Pay Later options—all in one seamless experience.

“We consistently hear from consumers that they want the freedom to choose how and when to pay - whether that’s paying now with debit or spreading the cost over time,” said David Sandström, Chief Marketing Officer at Klarna. “They want simplicity, flexibility, and transparency - all in one place. That’s exactly what has made Klarna payment methods so popular online, and now that same experience is coming to a physical card. The Klarna Card is the future of everyday banking - creating smart payments, to empower smarter shoppers.”

By combining access to spending, saving, and borrowing tools in one intuitive platform, Klarna is becoming a modern day global neobank for the digital-first consumer. The Klarna Card is a key step in this evolution - a transparent, tech-driven alternative to the products of traditional banks.

“Millions of people around the world have embraced the choice and control offered by Visa’s Flexible Credential, and we’re delighted to extend this to even more U.S. consumers, as well as bringing it to Europe for the first time,” added Mathieu Altwegg, SVP Product and Solutions, for Visa in Europe. “This is a pioneering example of a future where consumers will only need one card in order to have access to their preferred ways to pay, no matter where they are, or what they’re purchasing.”

*Klarna Card is issued by WebBank. Klarna balance account provided by WebBank, Member FDIC.

Notes to editors:

  • Flexible payment options: Pay up front in debit mode, or activate Klarna payment options and features, such as Pay in 4 and Pay Later, while also offering all the great features in the Klarna app including budgets, track spending reminders, among others.
  • Option to upgrade Tiers: Once available, customers will be able to choose between one free, or two paid tiers which include merchant discounts and improved cashback rates. The card will come in three colors: aubergine, black and bright green.
  • Available to all Klarna customers: Debit functionality is available to all; credit is granted on a case-by-case basis following a credit check.
  • Klarna Card availability: The Klarna Card is currently in testing in the U.S. as work is done with early users to evolve the final product. This test phase marks an important milestone in building financial solutions that meet real consumer needs. It will be available to all consumers in the U.S. in the coming months, with rollout in Europe expected to follow.
  • About Visa Flexible Credential: Visa Flexible Credential is a network capability that allows multiple payment experiences - such as debit, prepaid, credit, installments and rewards - to be accessed from a single card.

About Klarna

Klarna is on a mission to be available everywhere for everything. With over 100 million global active Klarna users and 2.9 million transactions per day, Klarna’s AI-powered payments and commerce network is empowering people to pay smarter — online, in-store and through Apple Pay in the U.S., UK and Canada. More than 724,000 retailers trust Klarna’s innovative solutions to drive growth and loyalty, including Uber, H&M, Saks, Sephora, Macy’s, Ikea, Expedia Group, Nike and Airbnb. For more information, visit Klarna.com.

About Visa

Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250603191998/en/

Contacts

Isobel Bradshaw
europeanmedia@visa.com
+44 20 7795 5336

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release

Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on

Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release

Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon

Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit

IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release

IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead

HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release

HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye